Sensus Healthcare(SRTS) - 2025 Q1 - Quarterly Results

Exhibit 99.1 ● Revenues were $8.3 million ● Net loss was $2.6 million, or $(0.16) per share ● Shipped 21 superficial radiotherapy (SRT) systems, including 15 to a large customer and one internationally ● Showcased SRT systems and several pre-commercial products at the 2025 Winter Clinical Dermatology Conference and at the 2025 American Academy of Dermatology (AAD) Annual Meeting, including hosting a highly successful event for customers and prospects First Quarter Financial Results Revenues were $8.3 millio ...